Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension

Roberto Pontremoli1, Giovanna Leoncini, Francesca Viazzi

  • 1Department of Internal Medicine, University of Genoa, Genoa, Italy. rpontrem@medicina.unige.it

Insights

Blood pressure (BP) alone is a poor predictor of cardiovascular risk. A comprehensive assessment including target organ damage, identified through methods like microalbuminuria screening, offers a more accurate risk evaluation for hypertensive patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Blood pressure (BP) levels alone are insufficient for accurately assessing individual cardiovascular risk.
  • The global cardiovascular profile, incorporating target organ damage, is a superior predictor of future adverse events.
  • Diagnostic techniques significantly influence the detection rate of target organ damage and patient risk stratification.

Purpose of the Study:

  • To evaluate the effectiveness of microalbuminuria screening in identifying high-risk hypertensive patients.
  • To optimize the cost-effectiveness of diagnostic workups in hypertension management.
  • To emphasize the importance of a comprehensive cardiovascular risk assessment beyond simple BP measurements.

Main Methods:

  • Analysis of diagnostic techniques for target organ damage in hypertensive patients.
  • Evaluation of the prevalence of high-risk patients identified through routine microalbuminuria testing.
  • Assessment of the cost-effectiveness of diagnostic strategies in hypertension.

Main Results:

  • Routine microalbuminuria screening detects a significantly higher percentage of high-risk hypertensive patients.
  • Comprehensive cardiovascular profiling, including target organ damage, improves risk prediction compared to BP levels alone.
  • Optimizing diagnostic workups enhances cost-effectiveness in managing hypertension.

Conclusions:

  • Microalbuminuria screening is a valuable tool for identifying high-risk individuals within the hypertensive population.
  • A holistic approach to cardiovascular risk assessment, beyond BP, is crucial for effective treatment and goal setting.
  • Balancing thorough diagnostics with cost-effectiveness is essential in public health strategies for hypertension.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
1.0K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
687